Rubinow DR - Search Results

1

Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion.

Kling MA, Rubinow DR, Doran AR, Roy A, Davis CL, Calabrese JR, Nieman LK, Post RM, Chrousos GP, Gold PW. Kling MA, et al. Among authors: rubinow dr. Neuroendocrinology. 1993 Jan;57(1):79-88. doi: 10.1159/000126345. Neuroendocrinology. 1993. PMID: 8097579

2

Neuroactive substances in cerebrospinal fluid. Normal and pathological regulatory mechanisms.

Post RM, Rubinow DR, Kling MA, Berrettini W, Gold PW. Post RM, et al. Among authors: rubinow dr. Ann N Y Acad Sci. 1988;531:15-28. doi: 10.1111/j.1749-6632.1988.tb31808.x. Ann N Y Acad Sci. 1988. PMID: 2898226 Review. No abstract available.

3

Somatostatin in neuropsychiatric disorders.

Rubinow DR, Davis CL, Post RM. Rubinow DR, et al. Prog Neuropsychopharmacol Biol Psychiatry. 1988;12 Suppl:S137-55. doi: 10.1016/0278-5846(88)90077-2. Prog Neuropsychopharmacol Biol Psychiatry. 1988. PMID: 2907936 Review.

4

Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.

Kling MA, Roy A, Doran AR, Calabrese JR, Rubinow DR, Whitfield HJ Jr, May C, Post RM, Chrousos GP, Gold PW. Kling MA, et al. Among authors: rubinow dr. J Clin Endocrinol Metab. 1991 Feb;72(2):260-71. doi: 10.1210/jcem-72-2-260. J Clin Endocrinol Metab. 1991. PMID: 1846869

5

Prednisone decreases CSF somatostatin in healthy humans: implications for neuropsychiatric illness.

Wolkowitz OM, Rubinow DR, Breier A, Doran AR, Davis C, Pickar D. Wolkowitz OM, et al. Among authors: rubinow dr. Life Sci. 1987 Oct 19;41(16):1929-33. doi: 10.1016/0024-3205(87)90745-4. Life Sci. 1987. PMID: 2889125

6

Testosterone suppression of CRH-stimulated cortisol in men.

Rubinow DR, Roca CA, Schmidt PJ, Danaceau MA, Putnam K, Cizza G, Chrousos G, Nieman L. Rubinow DR, et al. Neuropsychopharmacology. 2005 Oct;30(10):1906-12. doi: 10.1038/sj.npp.1300742. Neuropsychopharmacology. 2005. PMID: 15841103 Free PMC article. Clinical Trial.

7

ACTH and cortisol response to Dex/CRH testing in women with and without premenstrual dysphoria during GnRH agonist-induced hypogonadism and ovarian steroid replacement.

Lee EE, Nieman LK, Martinez PE, Harsh VL, Rubinow DR, Schmidt PJ. Lee EE, et al. Among authors: rubinow dr. J Clin Endocrinol Metab. 2012 Jun;97(6):1887-96. doi: 10.1210/jc.2011-3451. Epub 2012 Mar 30. J Clin Endocrinol Metab. 2012. PMID: 22466349 Free PMC article. Clinical Trial.

8

Hypothalamic-pituitary-adrenal function in patients with the premenstrual syndrome.

Rabin DS, Schmidt PJ, Campbell G, Gold PW, Jensvold M, Rubinow DR, Chrousos GP. Rabin DS, et al. Among authors: rubinow dr. J Clin Endocrinol Metab. 1990 Nov;71(5):1158-62. doi: 10.1210/jcem-71-5-1158. J Clin Endocrinol Metab. 1990. PMID: 2172272

9

Fluphenazine treatment reduces CSF somatostatin in patients with schizophrenia: correlations with CSF HVA.

Doran AR, Rubinow DR, Wolkowitz OM, Roy A, Breier A, Pickar D. Doran AR, et al. Among authors: rubinow dr. Biol Psychiatry. 1989 Feb 15;25(4):431-9. doi: 10.1016/0006-3223(89)90196-0. Biol Psychiatry. 1989. PMID: 2564787 Clinical Trial.

10

Effects of carbamazepine on cerebrospinal fluid somatostatin.

Rubinow DR, Post RM, Gold PW, Ballenger JC, Reichlin S. Rubinow DR, et al. Psychopharmacology (Berl). 1985;85(2):210-3. doi: 10.1007/BF00428416. Psychopharmacology (Berl). 1985. PMID: 2861620 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

319 results

Search Page

Filters